Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:XYZ_Biotech
|
| gptkbp:advertising |
gptkb:Dr._Emily_Johnson
|
| gptkbp:awards |
Best Workplace 2022
|
| gptkbp:benefits |
health insurance
flexible working hours paid time off retirement plans |
| gptkbp:budget |
2022 report available
|
| gptkbp:CEO |
gptkb:John_Smith
|
| gptkbp:clinicalTrials |
Phase IV
Phase II Phase III collaborative studies Phase I |
| gptkbp:collaborations |
international research institutes
with major hospitals |
| gptkbp:community_involvement |
scholarships for students
volunteer programs donations to health causes |
| gptkbp:community_outreach |
health fairs
|
| gptkbp:employees |
500
|
| gptkbp:founded |
1990
|
| gptkbp:future_plans |
increase market share
enhance research capabilities expand product portfolio improve patient access to medications |
| gptkbp:global_presence |
operates in 20 countries
|
| gptkbp:headquarters |
gptkb:New_York,_USA
|
| https://www.w3.org/2000/01/rdf-schema#label |
Benson Pharmaceutical
|
| gptkbp:investmentFocus |
publicly traded
$50 million in R&D |
| gptkbp:market |
gptkb:North_America
|
| gptkbp:mission |
improve patient health
|
| gptkbp:partnerships |
gptkb:ABC_University
with government agencies with healthcare providers with non-profits |
| gptkbp:patentCitation |
over 100
|
| gptkbp:productLine |
antibiotics
vaccines pain management cardiovascular drugs diabetes medications dermatology products neurology drugs |
| gptkbp:products |
prescription medications
|
| gptkbp:regulatoryCompliance |
FDA_approved
|
| gptkbp:research_focus |
oncology
|
| gptkbp:revenue |
$200 million
|
| gptkbp:social_responsibility |
community health initiatives
|
| gptkbp:subsidiary |
gptkb:Benson_Generics
|
| gptkbp:sustainability_initiatives |
green manufacturing practices
|
| gptkbp:training |
ongoing professional development
|
| gptkbp:vision |
leading innovator in pharmaceuticals
|
| gptkbp:website |
www.bensonpharma.com
|